# Navari Surgical

Source: https://onco.cc/companies/navari-surgical/  
OnCo record `navari-surgical` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Navari Surgical makes augmented reality software that overlays a view of structures inside an organ onto the camera image during keyhole or robotic cancer surgery. Its first product is for liver tumour operations and is being tested in a first feasibility study in patients.

## Summary

Navari Surgical AB, at Lennart Torstenssonsgatan 8, Gothenburg, Sweden, began as a research collaboration between Chalmers University of Technology and Sahlgrenska University Hospital and was developed further through Chalmers School of Entrepreneurship, with mathematicians Klas Modin and Torbjörn Lundh. It makes a manufacturer-agnostic, software-based intraoperative augmented reality tool for minimally invasive surgery: a plug-and-play box that adds an AR layer to the existing surgical video feed and a tablet interface for the surgeon, with a single-use device covered by patents filed in 2022, 2024 and 2025. The first commercial product is aimed at liver cancer surgery; a feasibility and safety study of AR in liver tumour surgery is registered. The company reported proof of concept in a preclinical in vivo study in September 2023. Its first registered cancer trial, NCT07630610, was posted on ClinicalTrials.gov in June 2026. It closed a pre-seed investment of SEK 7.5 million in October 2022 and was granted Vinnova funding under the call Acceleration of deeptech companies in March 2025; it also states it is funded by the European Union.

## Fields

- Kind: Company
- Last checked: 2026-10-29
- Also known as: Navari Surgical AB; Navari
- HQ: Gothenburg
- Type: devices
- Website: https://navarisurgical.com/

## Notes

- Founding year not stated on the company website.
-  The corpus has no technology record for surgical augmented reality, so none is linked.
- The company homepage carried unrelated injected Polish-language online casino text at the time of reading, which suggests the site has been compromised; the about, solution and news pages were read separately.
- Registry trial record not read in full; the description comes from its title and listed condition (liver neoplasms).
- Company website read on 29 October 2026.

## Sources

- Official website: https://navarisurgical.com/
- About Navari, including history and pre-seed round: https://navarisurgical.com/about/
- ClinicalTrials.gov: feasibility and safety of augmented reality in liver tumour surgery (NCT07630610): https://clinicaltrials.gov/study/NCT07630610

## Connected records

- fronts: [Devices & Physical Therapies](https://onco.cc/fronts/devices/), [Surgery & Interventional](https://onco.cc/fronts/surgery/)

---
JSON: https://onco.cc/api/v1/entities/navari-surgical.json